Perioperative nivolumab can improve event-free survival in patients with stage II-IIIB non-small cell lung cancer receiving neoadjuvant chemotherapy and surgery, a phase 3 trial suggests.

Findings on PET/CT conducted 1 week after the start of pembrolizumab may predict outcomes of the treatment in patients with advanced melanoma.

Triplet therapy of belantamab mafodotin, bortezomib, dexamethasone beneficial for relapsing or refractory multiple myeloma.

Using various assessment tools, researchers sought to determine the effects of chemotherapy on taste perception and eating behaviors in children with cancer.

Changes to modern treatment protocols for pediatric Hodgkin lymphoma seem to have reduced late cardiotoxicity.

Interval breast cancers and screen-detected breast cancers have distinct genetic profiles, according to researchers.

Individuals with previous major AFEs are more likely to be diagnosed with later-stage cancer in adjusted analyses.

A meta-analysis sought to determine the effect of evidence-based nursing care in patients with HCC undergoing surgery.

US lung cancer incidence and mortality rates continue to decline, but disparities remain across sexes and racial/ethnic groups.

Urinary incontinence persisted through 10 years after radical prostatectomy, however.